Lv3
296 积分 2026-09-04 加入
Recruitment and Residence of Intestinal T Cells - Lessons for Therapy in Inflammatory Bowel Disease
49分钟前
待确认
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
1小时前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
12天前
已完结
First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
13天前
已完结
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
14天前
已完结
Sevabertinib: First Approval
15天前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
19天前
已完结
Insight Into the Therapeutic Selectivity of the Irreversible EGFR Tyrosine Kinase Inhibitor Osimertinib Through Enzyme Kinetic Studies
20天前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
24天前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
24天前
已完结
皖公网安备34019202002308
